A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Seoul National University Bundang Hospital, Seongnam-si

UPMC Hillman Cancer Center, Pittsburgh

Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Madrid, Madrid

The START Center for Cancer Care - Madrid - CIOCC - Hospital Universitario Madrid Sanchinarro - Oncologia, Madrid

Universidad de Navarra - Centro de Investigacion Medica Aplicada (CIMA), Pamplona

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen

"START , San Antonio"

"Antwerp University Hospital , Oncology Department"

"Ghent University Hospital , Drug Research Unit Department"

National Cancer Center Hospital East, Kashiwa

Severance Hospital, Yonsei University Health System - Oncology Department, Seoul

Samsung Medical Center - Oncology Department, Seoul

Hospital Hm Nou Delfos - Oncologia, Barcelona

Hospital Universitari Vall d'Hebron - Institut d'Oncologia - Grupo de Tumores Toracicos y Cancer de Cabeza y Cuello, Barcelona

"Oxford University Hospitals NHS Foundation Trust , Churchill Hospital - Oncology"

Royal Marsden NHS Trust (Surrey), Sutton

Freeman Hospital, Newcastle

Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London